קלריטון
fischer pharmaceuticals ltd - benzalkonium chloride - טיפות עיניים - benzalkonium chloride 0.01 % - benzalkonium - benzalkonium - for rinsing and soothing the eyes against irritation due to various causes such as: dust, smoke, plants etc. for first aid use in helping remove a foreign body from the eye.
טיג'ל ג'ל
rafa laboratories ltd - cetalkonium chloride; choline salicylate - ג'ל - cetalkonium chloride 0.01 %w/w; choline salicylate 8.7 %w/w - choline salicylate - choline salicylate - as an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.
ביבי גאם
rafa laboratories ltd - cetalkonium chloride; choline salicylate - ג'ל - cetalkonium chloride 0.01 %w/w; choline salicylate 8.7 %w/w - choline salicylate - choline salicylate - as an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.
אקריזקס
trupharm marketing 1985 ltd. - dermatophagoides farina; dermatophagoides pteronyssinus - טבליה - dermatophagoides pteronyssinus 6 sq-hdm; dermatophagoides farina 6 sq-hdm - house dust
ez-talk
slp ltd. - כלל האוכלוסיה - טיפול נשימתי – הפרעות שינה
אמולסידרם
trupharm marketing 1985 ltd. - benzalkonium chloride 0.5 %w/v; isopropyl myristate 25 %w/v - emulsion - benzalkonium - for the treatment of dry skin conditions especially associated with eczema, ichtyosis or xeroderma. it permits rehydratation of the keratin.
walkaide system - functional electrical stimulation (fes) for treatment of foot drop
סטרייד אורטופדיה בע"מ - מומחה - מערכת הווקאייד - מכשיר גירוי חשמלי תפקודי לטיפול בצניחת כף רגל
קסאלקורי 200 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
קסאלקורי 200 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.